Loading organizations...
Loading organizations...
Developer of innovative anti-tumor drugs and pharmacological evaluation.
Haihe Biopharma has raised $171.1M across 1 funding round.
Haihe Biopharma has raised $171.1M in total across 1 funding round.
Haihe Biopharma has raised $171.1M in total across 1 funding round.
Haihe Biopharma's investors include Warburg Pincus, CMB International, CSPC Pharma, Legend Capital.
Haihe Biopharma has raised $171.1M across 1 funding round. Most recently, it raised $171.1M Series B in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 24, 2020 | $171.1M Series B | Warburg Pincus | CMB International, CSPC Pharma, Legend Capital |